Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Oral Dexamethasone for Paclitaxel Hypersensitivity
NCT02349763Phase 3Completed
- Sponsor
- Ministry of Public Health
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in Hypersensitivity reaction (2 arms), sponsored by Ministry of Public Health. Primary endpoint: Incidence of Paclitaxel-Associated Hypersensitivity Reaction and severe P-HSRs at 3 hours. Started Feb 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
Hypersensitivity reaction
Beyond the preview
Go deeper on NCT02349763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349763.